S&P Futures
5,880.50 -12.00 (-0.20%) Dow Futures
42,976.00 -193.00 (-0.45%) Nasdaq Futures
20,472.50 -69.50 (-0.34%) Russell 2000 Futures
2,239.70 -6.50 (-0.29%) Crude Oil
70.76 -0.98 (-1.37%) Gold
2,765.50 +5.70 (+0.21%)
Ecofibre Limited (EOF.AX)
Ecofibre Limited
680 George Street
Level 12
Sydney, NSW 2000
Australia
61 7 3265 7630
https://ecofibre.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees:
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jonathan Brown | CFO, Company Secretary and Interim President of Ecofibre Genetics | 251.52k | N/A | N/A |
| Mr. John Foley | Advisor | 639.25k | N/A | N/A |
| Mr. Ulrich Tombuelt | CEO, MD & Director | N/A | N/A | N/A |
| Ms. Robin Sheldon | General Counsel & Joint Company Secretary | N/A | N/A | N/A |
| Kate Douglass | Group Financial Controller & IT | N/A | N/A | N/A |
| Mr. Alex Nance | President of Ananda Health | N/A | N/A | N/A |
| Mr. Simon J. Allen B.Sc., M.B.A. | CEO of EOF Bio LLC | N/A | N/A | 1968 |
Description
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.
Corporate Governance
Ecofibre Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
